OBIC Co.,Ltd. (OBIIF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16,288	12,658	13,247	13,942	13,451	16,270
Market Cap Growth	50.83%	-4.44%	-4.99%	3.65%	-17.32%	39.00%
Enterprise Value	14,936	11,464	12,150	12,824	12,203	14,981
Last Close Price	34.50	27.91	30.84	31.25	30.57	41.80
PE Ratio	34.89	29.33	34.54	36.98	37.55	47.35
PS Ratio	18.82	15.63	17.95	18.50	18.26	21.46
PB Ratio	5.23	4.37	5.03	5.65	5.56	6.76
P/TBV Ratio	5.24	4.37	5.03	5.66	5.57	6.77
P/FCF Ratio	36.90	31.21	38.45	35.75	43.97	44.33
P/OCF Ratio	35.91	30.19	35.89	35.00	41.91	43.18
EV/Sales Ratio	17.61	14.16	16.47	17.02	16.56	19.76
EV/EBITDA Ratio	24.95	21.18	25.02	26.23	26.20	32.93
EV/EBIT Ratio	25.74	21.90	25.92	27.28	27.37	34.46
EV/FCF Ratio	33.84	28.27	35.27	32.89	39.89	40.82
Asset Turnover	0.26	0.25	0.27	0.29	0.29	0.30
Inventory Turnover	79.58	73.78	70.88	68.08	66.93	72.51
Quick Ratio	8.13	7.00	6.48	6.29	6.37	6.76
Current Ratio	8.19	7.13	6.56	6.35	6.46	6.81
Return on Equity (ROE)	15.80%	15.52%	15.97%	16.13%	15.55%	15.07%
Return on Assets (ROA)	10.15%	10.18%	10.69%	11.31%	10.88%	10.68%
Return on Capital (ROIC)	11.68%	11.77%	12.20%	12.57%	12.09%	11.92%
Return on Capital Employed (ROCE)	16.20%	16.70%	16.40%	18.40%	17.90%	17.50%
Earnings Yield	2.87%	3.41%	2.90%	2.70%	2.66%	2.11%
FCF Yield	2.71%	3.20%	2.60%	2.80%	2.27%	2.26%
Dividend Yield	1.46%	1.68%	1.29%	1.20%	1.16%	0.80%
Payout Ratio	45.71%	44.93%	41.28%	41.14%	40.33%	39.79%
Buyback Yield / Dilution	0.52%	0.72%	0.07%	0.12%	0.19%	0.00%
Total Shareholder Return	1.98%	2.40%	1.36%	1.32%	1.35%	0.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.